Unknown

Dataset Information

SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids.


ABSTRACT:

Background

Targeting viral cell entry proteins is an emerging therapeutic strategy for inhibiting the first stage of SARS-CoV-2 infection. In this study, 106 bioactive terpenoids from African medicinal plants were screened through molecular docking analysis against human angiotensin-converting enzyme 2 (hACE2), human transmembrane protease serine 2 (TMPRSS2), and the spike (S) proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV. In silico absorption-distribution-metabolism-excretion-toxicity (ADMET) and drug-likeness prediction, molecular dynamics (MD) simulation, binding free energy calculations, and clustering analysis of MD simulation trajectories were performed on the top docked terpenoids to respective protein targets.

Results

The results revealed eight terpenoids with high

SUBMITTER: Gyebi GA 

PROVIDER: S-EPMC8339396 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature